Genetic Disease
Advancing Genetic Disease Research with CRISPR
From Variant to Therapy: Decoding Genetic Diseases
Kim et al., Genome Biol, 2018
Explore Cell Models
Request Project DesignFrom Variant to Function: Identify Pathogenic Mutations
Genomic datasets often contain thousands of candidate variants per sample, yet only a subset contribute to disease phenotypes. Functional validation requires the ability to interrogate variants within their native chromatin and regulatory context, where epigenetic state, transcriptional regulation, and allele-specific effects can influence outcomes.
Leveraging CRISPR-mediated precision editing technologies (including base editing and prime editing), EDITGENE enables targeted introduction, correction, or modulation of variants at endogenous loci. This allows direct assessment of variant pathogenicity under controlled genetic backgrounds and supports rigorous genotype–phenotype mapping.
Explore Point Mutation Models
View Prime Editing SolutionsBuild Genotype-Defined Systems
A fundamental requirement for mechanistic studies in genetic disease is the use of genetically defined and reproducible model systems. Heterogeneous genetic backgrounds can obscure causal relationships and introduce variability in phenotypic readouts.
CRISPR-based genome engineering enables the generation of isogenic model systems, where only the variant of interest differs between experimental conditions. This design is critical for isolating the functional contribution of specific mutations and improving experimental reproducibility.
In addition, combining genome editing with advanced biological systems—such as iPSC-derived cells and organoids—allows disease modeling across multiple layers of biological organization, from molecular pathways to tissue-level phenotypes.
| Model Type | Applications | CRISPR Strategy |
| Immortalized cell lines | Mechanistic studies, high-throughput screening | Knockout, point mutation knock-in, CRISPR library screening |
| iPSC-derived cells | Disease-relevant cell types | Patient-derived iPSC editing, isogenic control generation |
| Organoids | Tissue-level function, developmental processes | Genome editing combined with organoid differentiation |
| Genetically engineered animals | In vivo mechanism, efficacy evaluation | Embryo editing, conditional knockout |
By controlling genetic background and editing precision, researchers can establish direct causal links between genetic variation and phenotypic outcomes, significantly enhancing data interpretability.
Explore Disease Models
Request Custom Model DevelopmentFrom Mechanism to Intervention
Cai et al., Genes Dis, 2016
Bridging the gap between genetic findings and therapeutic strategies requires systematic identification of disease-driving genes, modifier genes, and actionable intervention points. Functional genomics approaches are essential to move beyond correlation and establish therapeutic relevance.
CRISPR-based screening technologies—ranging from targeted perturbation to genome-wide knockout/activation libraries—enable unbiased discovery of genes that influence disease phenotypes. When combined with engineered disease models, these approaches support multi-layer validation of candidate targets.
Furthermore, precision editing technologies facilitate the evaluation of gene correction strategies, allele-specific interventions, and functional rescue experiments, providing critical insights into therapeutic feasibility.
CRISPR Strategies by Mutation Type
| Model Type | Recommended Strategy | Technical Considerations |
| Loss-of-function (LoF) point mutations | HDR-mediated precise correction | Donor template design is critical to improve repair efficiency |
| Gain-of-function (GoF) mutations | Allele-specific knockout | sgRNA design must leverage sequence differences |
| Repeat expansions | Selective disruption of mutant allele | Target expanded regions or flanking sequences |
| Large deletions | Gene replacement | Insert functional copies into safe harbor loci |
A Unified Path from Variant to Therapeutic Strategy
This unified framework reduces experimental fragmentation and accelerates the generation of reproducible, translatable insights.
Built for Precision and Speed
EDITGENE’s capabilities are supported by a robust technological foundation designed for accuracy, efficiency, and scalability:
Advanced Gene Editing Platforms
Integrating FLASH-KO™, Prime Editing (Bingo™), and HES-KI, our advanced platforms deliver efficient and reliable solutions for diverse gene editing needs.
Extensive Mutation Model Library
Covering key disease-associated genes such as CFTR, HTT, DMD, MECP2, MYH7, and more, our library supports a wide range of genetic disease studies.
Optimized Editing Strategies
Tailored CRISPR strategies for loss-of-function, gain-of-function, repeat expansions, and large deletions, ensuring precise and effective genome editing.
Monoclonal Validation with Sequencing Confirmation
Single-clone selection combined with Sanger and NGS validation ensures accuracy and reproducibility for every editing outcome.
Fast Turnaround for Custom Knockout Models
With a turnaround time as short as 5–10 weeks for custom knockout models, we significantly reduce project waiting time and accelerate your research.
Global Project Support and Delivery
Global Project Support and Delivery Backed by a mature global project collaboration and logistics system, we provide full-process support from technical consultation to final delivery.
